BIKTARVY is indicated as a complete regimen for the treatment of HIV-1 infection in adult and pediatric patients weighing ≥14 kg with no antiretroviral (ARV) treatment history; or with an ARV treatment history and not virologically suppressed, with no known or suspected substitutions associated with resistance to the integrase strand inhibitor class, emtricitabine, or tenofovir; or to replace the current ARV regimen in those who are virologically suppressed (HIV-1 RNA <50 copies per mL) on a stable ARV regimen with no known or suspected substitutions associated with resistance to bictegravir or tenofovir.
My primary focus was to act as the Creative Liaison to deliver quality creative and brand consistency by bridging the promotional side of BIKTARVY and its OLP (Opinion Leader Programming) initiatives. My initial scope of work consisted of an array of projects (both digital/print) to own and create, such as Leave Behinds, Person First Engagement (PFE) Flashcards, redesigning social media channels such as LinkedIn, extensive POA Guides and Mid-Year Meeting PPT decks, Unbranded Website redesigns, Emails and Email Headers, Brand Planning initiatives as well as aiding and supporting New Business Pitches.